BACITRACIN ZINC AND POLYMYXIN B SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bacitracin Zinc And Polymyxin B Sulfate, and what generic alternatives are available?
Bacitracin Zinc And Polymyxin B Sulfate is a drug marketed by Bausch And Lomb, Padagis Us, and Sciegen Pharms Inc. and is included in three NDAs.
The generic ingredient in BACITRACIN ZINC AND POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bacitracin Zinc And Polymyxin B Sulfate
A generic version of BACITRACIN ZINC AND POLYMYXIN B SULFATE was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB on January 26th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
- What are the global sales for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
- What is Average Wholesale Price for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
Summary for BACITRACIN ZINC AND POLYMYXIN B SULFATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | BACITRACIN ZINC AND POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Glaxo Wellcome | N/A |
National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
See all BACITRACIN ZINC AND POLYMYXIN B SULFATE clinical trials
Pharmacology for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Drug Class | Polymyxin-class Antibacterial |
Physiological Effect | Decreased Cell Wall Synthesis & Repair |
US Patents and Regulatory Information for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064046-001 | Jan 26, 1995 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Padagis Us | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022-001 | Feb 27, 2002 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sciegen Pharms Inc | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064028-001 | Jan 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |